Vanda Pharmaceuticals Inc. SEC filings VNDA
Vanda Pharmaceuticals Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jun 10, 2009. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 23, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Feb 12, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Feb 14, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 8, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 24, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 9, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 24, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Feb 11, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Feb 26, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Feb 19, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Feb 15, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Feb 17, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Feb 12, 2016 | Dec 31, 2015 |
| 10-K/A | Amended annual report | Jun 10, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Mar 13, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Feb 25, 2014 | Dec 31, 2013 |
| 10-K | Annual report | Feb 26, 2013 | Dec 31, 2012 |
| 10-K | Annual report | Mar 9, 2012 | Dec 31, 2011 |
| 10-K | Annual report | Mar 10, 2011 | Dec 31, 2010 |
| 10-K | Annual report | Mar 15, 2010 | Dec 31, 2009 |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VNDA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Washington, DC
- SEC filer status
- Accelerated filer
- SEC CIK
- 1347178
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.